Android app on Google Play

Barclays Upgrades GlaxoSmithKline (GSK) to Overweight

January 29, 2013 9:10 AM EST Send to a Friend
Get Alerts GSK Hot Sheet
Price: $52.67 +0.67%

Rating Summary:
    2 Buy, 10 Hold, 4 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 31 | Down: 9 | New: 29
Trade GSK Now!
Join SI Premium – FREE
Barclays upgraded GlaxoSmithKline (NYSE: GSK) from Equalweight to Overweight.

For an analyst ratings summary and ratings history on GlaxoSmithKline click here. For more ratings news on GlaxoSmithKline click here.

Shares of GlaxoSmithKline closed at $44.56 yesterday.




You May Also Be Interested In


Related Categories

Upgrades

Related Entities

Barclays

Add Your Comment